These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26545309)

  • 1. Optical diagnostics study of air flow and powder fluidisation in Nexthaler®--Part I: Studies with lactose placebo formulation.
    Pasquali I; Merusi C; Brambilla G; Long EJ; Hargrave GK; Versteeg HK
    Int J Pharm; 2015 Dec; 496(2):780-91. PubMed ID: 26545309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optical diagnostics studies of air flow and powder fluidisation in Nexthaler®. Part II: Use of fluorescent imaging to characterise transient release of fines from a dry powder inhaler.
    Merusi C; Brambilla G; Long EJ; Hargrave GK; Versteeg HK
    Int J Pharm; 2018 Oct; 549(1-2):96-108. PubMed ID: 30017819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An insight into powder entrainment and drug delivery mechanisms from a modified Rotahaler®.
    Sim S; Margo K; Parks J; Howell R; Hebbink GA; Orlando L; Larson I; Leslie P; Ho L; Morton DA
    Int J Pharm; 2014 Dec; 477(1-2):351-60. PubMed ID: 25196720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential and constraints for the application of CFD combined with Lagrangian particle tracking to dry powder inhalers.
    Sommerfeld M; Cui Y; Schmalfuß S
    Eur J Pharm Sci; 2019 Feb; 128():299-324. PubMed ID: 30553814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Flow Rate on In Vitro Aerodynamic Performance of NEXThaler(®) in Comparison with Diskus(®) and Turbohaler(®) Dry Powder Inhalers.
    Buttini F; Brambilla G; Copelli D; Sisti V; Balducci AG; Bettini R; Pasquali I
    J Aerosol Med Pulm Drug Deliv; 2016 Apr; 29(2):167-78. PubMed ID: 26355743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Powder dispersion mechanisms within a dry powder inhaler using microscale particle image velocimetry.
    Kou X; Wereley ST; Heng PW; Chan LW; Carvajal MT
    Int J Pharm; 2016 Dec; 514(2):445-455. PubMed ID: 27497998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and Evaluation of Surface Modified Lactose Particles for Improved Performance of Fluticasone Propionate Dry Powder Inhaler.
    Singh DJ; Jain RR; Soni PS; Abdul S; Darshana H; Gaikwad RV; Menon MD
    J Aerosol Med Pulm Drug Deliv; 2015 Aug; 28(4):254-67. PubMed ID: 25517187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental and computational study of the effect of breath-actuated mechanism built in the NEXThaler
    Farkas Á; Lewis D; Church T; Tweedie A; Mason F; Haddrell AE; Reid JP; Horváth A; Balásházy I
    Int J Pharm; 2017 Nov; 533(1):225-235. PubMed ID: 28941830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulating powder-device combinations for salmeterol xinafoate dry powder inhalers.
    Hassoun M; Ho S; Muddle J; Buttini F; Parry M; Hammond M; Forbes B
    Int J Pharm; 2015 Jul; 490(1-2):360-7. PubMed ID: 25987210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agglomerate behaviour of fluticasone propionate within dry powder inhaler formulations.
    Le VN; Robins E; Flament MP
    Eur J Pharm Biopharm; 2012 Apr; 80(3):596-603. PubMed ID: 22198291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler.
    de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Frijlink HW
    Int J Pharm; 2006 Mar; 310(1-2):81-9. PubMed ID: 16442246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation of novel dry powder inhalation for fluticasone propionate and salmeterol xinafoate with capsule-based device.
    Kim KS; Kim JH; Jin SG; Kim DW; Kim JO; Yong CS; Youn YS; Oh KT; Woo JS; Choi HG
    Pharm Dev Technol; 2018 Feb; 23(2):158-166. PubMed ID: 28612675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental observations of dry powder inhaler dose fluidisation.
    Tuley R; Shrimpton J; Jones MD; Price R; Palmer M; Prime D
    Int J Pharm; 2008 Jun; 358(1-2):238-47. PubMed ID: 18457930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of carrier particle shape on dry powder inhaler performance.
    Kaialy W; Alhalaweh A; Velaga SP; Nokhodchi A
    Int J Pharm; 2011 Dec; 421(1):12-23. PubMed ID: 21945739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Air permeability of powder: a potential tool for Dry Powder Inhaler formulation development.
    Le VN; Robins E; Flament MP
    Eur J Pharm Biopharm; 2010 Nov; 76(3):464-9. PubMed ID: 20854906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing the particulate microstructure of the aerodynamic particle size distribution of dry powder inhaler combination products.
    Jetzer MW; Morrical BD; Schneider M; Edge S; Imanidis G
    Int J Pharm; 2018 Mar; 538(1-2):30-39. PubMed ID: 29289516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accessorized DPI: a Shortcut towards Flexibility and Patient Adaptability in Dry Powder Inhalation.
    Buttini F; Hannon J; Saavedra K; Rossi I; Balducci AG; Smyth H; Clark A; Colombo P
    Pharm Res; 2016 Dec; 33(12):3012-3020. PubMed ID: 27623625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dry powders for oral inhalation free of lactose carrier particles.
    Healy AM; Amaro MI; Paluch KJ; Tajber L
    Adv Drug Deliv Rev; 2014 Aug; 75():32-52. PubMed ID: 24735676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of exhalation before the inhalation of dry powder aerosol drugs on the breathing parameters, emitted doses and aerosol size distributions.
    Farkas Á; Tomisa G; Kugler S; Nagy A; Vaskó A; Kis E; Szénási G; Gálffy G; Horváth A
    Int J Pharm X; 2023 Dec; 5():100167. PubMed ID: 36824288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental investigation of design parameters on dry powder inhaler performance.
    Ngoc NT; Chang L; Jia X; Lau R
    Int J Pharm; 2013 Nov; 457(1):92-100. PubMed ID: 24055597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.